SEC Form 4 · accession 0001144204-18-062678
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Jay Lobell
Director
Period of report
Jan 1, 2018
Accepted (ET)
Nov 30, 2018 · 5:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 1, 2018 | A | 100,000 | $0.00 | A | 786,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1One-third of the shares will vest on each of January 1, 2019, 2020, and 2021, subject to continued service.